DILH
ISEE

Dai-ichi Life Holdings’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Dai-ichi Life Holdings’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-23,123
Closed -$1.07M – 481
2016
Q3 		$1.07M Buy
23,123
+1,452
+7% +$81.9K 0.03% 401
2016
Q2 		$1.11M Buy
+21,671
New +$1.08M 0.03% 389

Other funds holding ISEE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dai-ichi Life Holdings's ISEE Position: Q4 2016 in Review

Dai-ichi Life Holdings sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2016, closing a stake of 23,123 shares — an estimated $1.07M sold.

Dai-ichi Life Holdings first reported a position in ISEE in Q2 2016 and held it in 2 quarters. The position peaked at $1.11M in Q2 2016. 137 funds tracked by Wall St. Rank hold ISEE as of Q4 2016.

  • Dai-ichi Life Holdings reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
  • Dai-ichi Life Holdings sold 23,123 IVERIC bio, Inc. Common Stock shares in Q4 2016, an estimated $1.07M.
  • Dai-ichi Life Holdings first reported a position in IVERIC bio, Inc. Common Stock in Q2 2016 and held it in 2 quarters.
  • Dai-ichi Life Holdings's IVERIC bio, Inc. Common Stock position peaked at $1.11M in Q2 2016.
  • 137 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2016.

Based on Dai-ichi Life Holdings's 13F filing for Q4 2016, filed 14 Feb 2017.